U.S. Psychiatric and Mental Health Congress
SEPTEMBER 6-10, 2023
NASHVILLE, TN
CLINICAL POSTERS
The scientific posters accessible via this website have been developed and financially supported by Sumitomo Pharma America, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc.
Copies of posters obtained through this site are for personal use only and may not be reproduced without written permission from the authors.
REAL-WORLD PREDICTORS OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS IN A LARGE HEALTH SYSTEM
Anne Rivelli, MPH, MA; Veronica Fitzpatrick, DrPH; Michael Nelson, PharmD, RPh; Kimberly Laubmeier, PhD; Courtney Zeni, PhD; Srikrishna Mylavarapu, MD, FAPA
Download the PDF: CLICK HERE
View interactive iPoster: CLICK HERE
HEALTHCARE RESOURCE USE AND COST ASSOCIATED WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
Soumak Basumallik, Monika Semwal, MosadoluwaAfolabi, Gideon Aweh, Xue Han, Michael Tocco, Amit Kulkarni, Carole Dembek
Download the PDF: CLICK HERE
View interactive iPoster: CLICK HERE
PREVALENCE OF CONCOMITANT MEDICATIONS AMONG PATIENTS WITH SCHIZOPHRENIA PRESCRIBED ATYPICAL ANTIPSYCHOTICS
Yifei Wang, Monika Semwal, Courtney Zeni, Carole Dembek
Download the PDF: CLICK HERE
View interactive iPoster: CLICK HERE
BEST PRACTICES FOR MENTAL HEALTH TREATMENT TEAMS FROM THE PERSPECTIVE OF CERTIFIED PEER SUPPORT SPECIALISTS (CPSS): RESULTS OF A CPSS ROUNDTABLE
LaGenia Bailey, PharmD, BCPP, Beth Bloom, BFA, CRPA, Cynthia A Bartholomew Millsap, CPS, CPRP, John G Holley, MHP, CRSS/CRPS, Mary Tolle, MA, MHPS, PSS, Tricia Kregg, BS, CPSS, Lillian Moffitt, PSS, PWS, CPMC, Michael Tocco, PhD, Samantha Koth, MBA, Melissa Santiago, PhD
Download the PDF: CLICK HERE
View interactive iPoster: CLICK HERE